The CEO stated!?! Really??? That anyone would trade on the statements of this CEO? While I am unable to find your stated claim for 2023 I can find cash flow claims going back as far as July 2021 when they bought into their 75% ownership. That claimed ownership by the way is really held by secured debt holders.
July 2021 press release statement about debt payments with cash flow. What really happened in Q3 and Q4 2021 was right at 1 billion new shares printed for debt taking the price down to .001.
March 2022 statement about using cash flow to make those Labrys payments. What really happened? Not a single payment made and the $596K of defaulted Labrys debt was exchanged for the new $745K Leonite note dated June 1st 2022 that matures March 1st 2023.
July 2022 8K debt restructuring 8K for the $745K Leonite exchange note the CEO reported that they will use cash flow to "repay the note in full prior to maturity". The Q3 filing revealed that they apparently haven't even made the monthly interest payments resulting in an accrued value of the note totaling $772,178 as of September 30th 2022. This note matures March 1st with 24% interest calculated back to day one of the note.
Where is cash flow really going. They borrowed $550K against future receipts in Q2 and Q3 2022 and likely continued that in Q4 and Q1 2023.
Yet the CEO stated they will pay off most debt with the revenues they will make in 2023.
...The Company retains the right to repay the debt it still owed and expects to begin using the cash it receives from ARIA as repayments of its loans to pay down more debt in order to reduce further conversions...
....balance to be paid in the following amounts on the following dates; $100,000.00 on March 31, 2022, $150,000.00 on April 30, 2022 and $136,000.00 on May 31, 2022...
...as long as the note is repaid in two equal payments of $127,650.00 on May 31, 2022 and June 30, 2022...
Mr. Shawn Leon, Company CEO, reported, ...
...We will use cash flow from operations, new fixed rate debt, and market rate equity to do our very best to make this happen in the first half of 2022.”...
...The new note extends the maturity for 9 months from June 1, 2022 and it also allows the Company to avoid further costs built into the note if the original amount owing under the Labrys notes is paid off by October 3, 2022....
This will enable the Company more time to generate cash flow for repayment of the debt. The Company’s ARIA subsidiary is steadily increasing cash flow and should generate enough to repay the note in full prior to maturity.”
On May 31, 2022 the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement with Itria Ventures LLC (“Itria”), whereby $240,000 the Receivables of Evernia were sold to Itria, for gross proceeds of $200,000...
On September 26, 2022, the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement with Itria Ventures LLC (“Itria”), whereby $310,000 of the Receivables of Evernia were sold to Itria, for gross proceeds of $250,000....
News 
Market Data 
Discover 
AI
